Clinical Trial Update: Evaluating Cascade Communication Methods

View source ↗

Summary

A completed University of Pennsylvania clinical trial evaluating cascade communication methods for individuals with BRCA1 or BRCA2 mutations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Snippet

Sponsor: University of Pennsylvania | Conditions: BRCA1 Mutation, BRCA2 Mutation | Status: COMPLETED